Pasar al contenido principal

NUEVOS ACTORES CON POTENCIAL PARA REGULAR LA DIFERENCIACION, ACTIVACION Y MIGRACION LINFOCITARIA EN EL MICROAMBIENTE TUMORAL

PID2020-116303RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biomechanical properties of laminins and their impact on cancer progression

  • Nonnast, Elena
  • Mira, Emilia
  • Mañes, Santos
Laminins (LMs) constitute a family of heterotrimeric glycoproteins essential for the formation of basement membranes (BM). They act as molecular bridges between cells and the extracellular matrix (ECM), thereby transmitting signals influencing cell behavior and tissue organization. In the realm of cancer pathobiology, LMs regulate key processes such as migration, differentiation, or fibrosis. This review critically examines the multifaceted impact of LMs on tumor progression, with a particular focus on the isoform-specific structure-function relationships, and how this structural diversity contributes to the biomechanical properties of BMs. LM interactions with integrin and non-integrin cell surface receptors, as well as with other ECM proteins, modify the response of cancer cells to the ECM stiffness, ultimately influencing the capacity of malignant cells to breach the BM, a limiting step in metastatic dissemination. Comprehension of the mechanisms underlying LM-driven tumor biomechanics holds potential for better understand cancer pathobiology and design new targeted therapeutic strategies., Our research was funded by the Spanish Ministry of Science, Innovation and Universities (MCINU/AEI/10.13039/501100011033) grants PID2020-116303RB-I00 and PID2023-147125OB-I00, and the Asociación Española Contra el Cancer (AECC) Foundation (PRYGN211240MANE). EN was supported by a predoctoral fellowship from the Spanish Ministry of Science, Innovation and Universities and the EU European Social Fund (PRE2021-097603). SM belongs to the Spanish National Research Council (CSIC)’s Cancer Hub., Peer reviewed